Previous studies showed that COX2 inhibitors, such as nonsteroidal anti-inflammatory drugs (NSAIDs), may decrease the risk and improve prognosis of carcinogenesis of various types of cancer including colorectal cancer [21,22,23,24]. Here, PTGS2 is linked to colorectal cancer.